0001209191-19-035568.txt : 20190607
0001209191-19-035568.hdr.sgml : 20190607
20190607163755
ACCESSION NUMBER: 0001209191-19-035568
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190607
FILED AS OF DATE: 20190607
DATE AS OF CHANGE: 20190607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McArthur James G
CENTRAL INDEX KEY: 0001763307
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38217
FILM NUMBER: 19886169
MAIL ADDRESS:
STREET 1: NIGHTSTAR THERAPEUTICS PLC
STREET 2: 203 CRESCENT STREET, SUITE 303
CITY: WALTHAM
STATE: MA
ZIP: 02453
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nightstar Therapeutics plc
CENTRAL INDEX KEY: 0001711675
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O NIGHTSTAR, INC.
STREET 2: 203 CRESCENT STREET, SUITE 303
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 781-778-7553
MAIL ADDRESS:
STREET 1: C/O NIGHTSTAR, INC.
STREET 2: 203 CRESCENT STREET, SUITE 303
CITY: WALTHAM
STATE: MA
ZIP: 02453
FORMER COMPANY:
FORMER CONFORMED NAME: Nightstar Therapeutics Ltd
DATE OF NAME CHANGE: 20170712
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-07
0
0001711675
Nightstar Therapeutics plc
NITE
0001763307
McArthur James G
C/O NIGHTSTAR, INC.
203 CRESCENT STREET, SUITE 303
WALTHAM
MA
02453
1
0
0
0
Ordinary Shares
2019-06-07
4
D
0
37237
25.50
D
0
D
Stock Option (Right to Buy)
12.27
2019-06-07
4
D
0
18200
13.23
D
2028-02-27
Ordinary Shares
18200
0
D
Stock Option (Right to Buy)
13.57
2019-06-07
4
D
0
21000
11.93
D
2029-01-24
Ordinary Shares
21000
0
D
The ordinary shares, nominal value GBP 0.01 per share, of Nightstar Therapeutics plc (the "Issuer") may be represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
In connection with the acquisition by Tungsten Bidco Limited of the entire issued and to be issued share capital of the Issuer on June 7, 2019 by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006, all stock options were cancelled in exchange for a payment equal to $25.50 with respect to each ordinary share subject to the option award, less the applicable exercise price.
Represents the payment per share received in exchange for the cancellation of each option of $25.50, less the applicable exercise price.
/s/ Bryan Yoon, Attorney-in-Fact
2019-06-07